25T2-NBOMe

25T2-NBOMe
Clinical data
Other names	2C-T-2-NBOMe; NBOMe-2C-T-2; N-(2-Methoxybenzyl)-4-ethylthio-2,5-dimethoxyphenethylamine
Drug class	Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Identifiers
	IUPAC name 2-(4-ethylsulfanyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine;
CAS Number	1391492-27-5;
PubChem CID	129514317;
CompTox Dashboard (EPA)	DTXSID301342515 ;
Chemical and physical data
Formula	C20H27NO3S
Molar mass	361.50 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCSC1=C(C=C(C(=C1)OC)CCNCC2=CC=CC=C2OC)OC;
	InChI InChI=1S/C20H27NO3S/c1-5-25-20-13-18(23-3)15(12-19(20)24-4)10-11-21-14-16-8-6-7-9-17(16)22-2/h6-9,12-13,21H,5,10-11,14H2,1-4H3; Key:OZEBFZPAWCXEGK-UHFFFAOYSA-N;

25T2-NBOMe is a serotonergic psychedelic of the 25-NB (NBOMe) family. It is the NBOMe analogue of 2C-T-2. The drug acts as a highly potent and selective agonist of the serotonin 5-HT₂ receptors. Its affinities and activities at a variety of other receptors and transporters have also been described. 25T2-NBOMe's reported active dose range has been described as 100 to 1,000 μg, with a typical dose estimate of 500 μg. 25T2-NBOMe was first described in the scientific literature by at least 2012.